Pearl River Capital’s Medicines Co MDCO Stock Holding History

Pearl River Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-988	Closed	-$19K	–	971
2018 Q4	$19K	Buy	+988	New	+$23K	0.09%	318

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Pearl River Capital's MDCO Position: Q1 2019 in Review

Pearl River Capital sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 988 shares — an estimated $19K sold.

Pearl River Capital first reported a position in MDCO in Q4 2018 and held it in 1 quarter. The position peaked at $19K in Q4 2018. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

Pearl River Capital reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
Pearl River Capital sold 988 Medicines Co shares in Q1 2019, an estimated $19K.
Pearl River Capital first reported a position in Medicines Co in Q4 2018 and held it in 1 quarter.
Pearl River Capital's Medicines Co position peaked at $19K in Q4 2018.
203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.